BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Islas JF, Moreno-Cuevas JE. A MicroRNA Perspective on Cardiovascular Development and Diseases: An Update. Int J Mol Sci 2018;19:E2075. [PMID: 30018214 DOI: 10.3390/ijms19072075] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Reis-ferreira A, Neto-mendes J, Brás-silva C, Lobo L, Fontes-sousa AP. Emerging Roles of Micrornas in Veterinary Cardiology. Veterinary Sciences 2022;9:533. [DOI: 10.3390/vetsci9100533] [Reference Citation Analysis]
2 Fayez SS, Mishlish SM, Saied HM, Shaban SA, Suleiman AA, Hassan F, Al-saffar AZ, Al-obaidi JR, Fan C. Role of Different Types of miRNAs in Some Cardiovascular Diseases and Therapy-Based miRNA Strategies: A Mini Review. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/2738119] [Reference Citation Analysis]
3 Cheong JK, Rajgor D, Lv Y, Chung KY, Tang YC, Cheng H. Noncoding RNome as Enabling Biomarkers for Precision Health. IJMS 2022;23:10390. [DOI: 10.3390/ijms231810390] [Reference Citation Analysis]
4 Yang Y, Yang H, Lian X, Yang S, Shen H, Wu S, Wang X, Lyu G. Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects. Front Genet 2022;13:899034. [DOI: 10.3389/fgene.2022.899034] [Reference Citation Analysis]
5 Ramachandran V, Bhagavatheeswaran S, Shanmugam S, Vasudevan M, Ragunathan M, Cherian KM, Munirajan AK, Ravi S, Balakrishnan A. Deep sequencing unveils altered cardiac miRNome in congenital heart disease. Mol Genet Genomics 2022. [PMID: 35668131 DOI: 10.1007/s00438-022-01908-z] [Reference Citation Analysis]
6 Rencelj A, Gvozdenovic N, Cemazar M. MitomiRs: their roles in mitochondria and importance in cancer cell metabolism. Radiol Oncol 2021;55:379-92. [PMID: 34821131 DOI: 10.2478/raon-2021-0042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
7 Xie W, Sun H, Li X, Lin F, Wang Z, Wang X. Ovarian cancer: epigenetics, drug resistance, and progression. Cancer Cell Int 2021;21:434. [PMID: 34404407 DOI: 10.1186/s12935-021-02136-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
8 Taverner D, Llop D, Rosales R, Ferré R, Masana L, Vallvé JC, Paredes S. Plasma expression of microRNA-425-5p and microRNA-451a as biomarkers of cardiovascular disease in rheumatoid arthritis patients. Sci Rep 2021;11:15670. [PMID: 34341435 DOI: 10.1038/s41598-021-95234-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Sahranavardfard P, Madjd Z, Emami Razavi AN, Ghanadan AR, Firouzi J, Khosravani P, Ghavami S, Ebrahimie E, Ebrahimi M. An Integrative Analysis of The Micro-RNAs Contributing in Stemness, Metastasis and B-Raf Pathways in Malignant Melanoma and Melanoma Stem Cell. Cell J 2021;23:261-72. [PMID: 34308569 DOI: 10.22074/cellj.2021.7311] [Reference Citation Analysis]
10 Quiroz-Reyes AG, Delgado-Gonzalez P, Islas JF, Gallegos JLD, Martínez Garza JH, Garza-Treviño EN. Behind the Adaptive and Resistance Mechanisms of Cancer Stem Cells to TRAIL. Pharmaceutics 2021;13:1062. [PMID: 34371753 DOI: 10.3390/pharmaceutics13071062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Turunen T, Hernández de Sande A, Pölönen P, Heinäniemi M. Genome-wide analysis of primary microRNA expression using H3K36me3 ChIP-seq data. Comput Struct Biotechnol J 2021;19:1944-55. [PMID: 33995896 DOI: 10.1016/j.csbj.2021.03.035] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chua SK, Wang BW, Yu YJ, Fang WJ, Lin CM, Shyu KG. Cyclic stretching boosts microRNA-499 to regulate Bcl-2 via microRNA-208a in atrial fibroblasts. J Cell Mol Med 2021;25:3113-23. [PMID: 33605072 DOI: 10.1111/jcmm.16373] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Quiroz-Reyes AG, Islas JF, Delgado-Gonzalez P, Franco-Villarreal H, Garza-Treviño EN. Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma. Pharmaceutics 2021;13:103. [PMID: 33466892 DOI: 10.3390/pharmaceutics13010103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Kalayinia S, Arjmand F, Maleki M, Malakootian M, Singh CP. MicroRNAs: roles in cardiovascular development and disease. Cardiovasc Pathol 2021;50:107296. [PMID: 33022373 DOI: 10.1016/j.carpath.2020.107296] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 17.5] [Reference Citation Analysis]
15 Piccioni A, Valletta F, Zanza C, Esperide A, Franceschi F. Novel biomarkers to assess the risk for acute coronary syndrome: beyond troponins. Intern Emerg Med 2020;15:1193-9. [PMID: 32621267 DOI: 10.1007/s11739-020-02422-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lu G, Tian P, Zhu Y, Zuo X, Li X. LncRNA XIST knockdown ameliorates oxidative low-density lipoprotein-induced endothelial cells injury by targeting miR-204-5p/TLR4. J Biosci 2020;45. [DOI: 10.1007/s12038-020-0022-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
17 Lin C, Fang W, Wang B, Pan C, Chua S, Hou S, Shyu K. (-)-Epigallocatechin Gallate Promotes MicroRNA 145 Expression against Myocardial Hypoxic Injury through Dab2/Wnt3a/β-catenin. Am J Chin Med 2020;48:341-56. [DOI: 10.1142/s0192415x20500172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
18 Navarro E, Mallén A, Cruzado JM, Torras J, Hueso M. Unveiling ncRNA regulatory axes in atherosclerosis progression. Clin Transl Med 2020;9:5. [PMID: 32009226 DOI: 10.1186/s40169-020-0256-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
19 Qiu Y, Cheng R, Liang C, Yao Y, Zhang W, Zhang J, Zhang M, Li B, Xu C, Zhang R. MicroRNA-20b Promotes Cardiac Hypertrophy by the Inhibition of Mitofusin 2-Mediated Inter-organelle Ca2+ Cross-Talk. Mol Ther Nucleic Acids 2020;19:1343-56. [PMID: 32160705 DOI: 10.1016/j.omtn.2020.01.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
20 Liu H, Wang H, Yang S, Qian D. Downregulation of miR-542-3p promotes osteogenic transition of vascular smooth muscle cells in the aging rat by targeting BMP7. Hum Genomics 2019;13:67. [PMID: 31829291 DOI: 10.1186/s40246-019-0245-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
21 García-Padilla C, Domínguez JN, Aránega AE, Franco D. Differential chamber-specific expression and regulation of long non-coding RNAs during cardiac development. Biochim Biophys Acta Gene Regul Mech 2019;1862:194435. [PMID: 31678627 DOI: 10.1016/j.bbagrm.2019.194435] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
22 Chen Y, Ye X, Yan F. MicroRNA 3113-5p is a novel marker for early cardiac ischemia/reperfusion injury. Diagn Pathol 2019;14:121. [PMID: 31672150 DOI: 10.1186/s13000-019-0894-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Szabó IA, Frigy A. MicroRNAs as Biomarkers and Therapeutic Targets in Heart Failure. Acta Medica Marisiensis 2019;65:77-9. [DOI: 10.2478/amma-2019-0016] [Reference Citation Analysis]
24 Nagy O, Baráth S, Ujfalusi A. The role of microRNAs in congenital heart disease. EJIFCC 2019;30:165-78. [PMID: 31263391] [Reference Citation Analysis]
25 Kim EN, Kim CJ, Kim SR, Song JA, Choe H, Kim KB, Choi JS, Oh SJ. High serum CRP influences myocardial miRNA profiles in ischemia-reperfusion injury of rat heart. PLoS One 2019;14:e0216610. [PMID: 31063484 DOI: 10.1371/journal.pone.0216610] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
26 Yoshikawa Y, Hirata N, Terada H, Sawashita Y, Yamakage M. Identification of Candidate Genes and Pathways in Dexmedetomidine-Induced Cardioprotection in the Rat Heart by Bioinformatics Analysis. Int J Mol Sci 2019;20:E1614. [PMID: 30939728 DOI: 10.3390/ijms20071614] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
27 Dueñas A, Expósito A, Aranega A, Franco D. The Role of Non-Coding RNA in Congenital Heart Diseases. J Cardiovasc Dev Dis 2019;6:E15. [PMID: 30939839 DOI: 10.3390/jcdd6020015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
28 He R, Ding C, Yin P, He L, Xu Q, Wu Z, Shi Y, Su L. MiR-1a-3p mitigates isoproterenol-induced heart failure by enhancing the expression of mitochondrial ND1 and COX1. Exp Cell Res 2019;378:87-97. [PMID: 30853447 DOI: 10.1016/j.yexcr.2019.03.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
29 Zhang L, Liao Y, Tang L. MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. J Exp Clin Cancer Res 2019;38:53. [PMID: 30717802 DOI: 10.1186/s13046-019-1059-5] [Cited by in Crossref: 192] [Cited by in F6Publishing: 208] [Article Influence: 64.0] [Reference Citation Analysis]
30 Lei Y, Peng X, Li T, Liu L, Yang G. ERK and miRNA-1 target Cx43 expression and phosphorylation to modulate the vascular protective effect of angiotensin II. Life Sciences 2019;216:59-66. [DOI: 10.1016/j.lfs.2018.11.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
31 Guerrero Orriach JL, Escalona Belmonte JJ, Ramirez Aliaga M, Ramirez Fernandez A, Raigón Ponferrada A, Rubio Navarro M, Cruz Mañas J. Anesthetic-induced Myocardial Conditioning: Molecular Fundamentals and Scope. Curr Med Chem 2020;27:2147-60. [PMID: 30259804 DOI: 10.2174/0929867325666180926161427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]